63
Views
1
CrossRef citations to date
0
Altmetric
Review

Considerations for payers in managing hormone receptor-positive advanced breast cancer

&
Pages 331-339 | Published online: 10 Jul 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nanxin Li, Yanni Hao, Valerie Koo, Anna Fang, Miranda Peeples, Andrew Kageleiry, Eric Q. Wu & Annie Guérin. (2016) Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2− metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis. Journal of Medical Economics 19:4, pages 414-423.
Read now